Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin versus placebo before surgical release for elbow contracture
ACTRN12622001433796Phase 4Recruiting
- Sponsor
- John Trantalis
- Start
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Elbow contracture comparing Botulinum toxin plus standard surgical care with Placebo plus standard surgical care (2 arms). Primary endpoints: Elbow flexion-extension range of motion and Elbow pronation-supination range of motion. Started Dec 2022; status: recruiting.
02
Drugs
neuronox
03
Conditions
Elbow contracture
Beyond the preview
Go deeper on ACTRN12622001433796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001433796.